An evaluation of venous thromboembolic risk in acutely ill medical patients immobilized at home: The AT-HOME study

Clinical and Applied Thrombosis/Hemostasis

Volumn 13, Issue 1, 2007, Pages 7-13

  Haas, Sylvia K ^a   Hach Wunderle, Viola ^b   Mader, Frank H ^c   Ruster, Katherine ^d   Paar, Wilhelm D ^d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Institute for Vascular Medicine   (Germany)

^c Sanofi Aventis Pharma Germany ^*  (Germany)

^d SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

AT HOME study; Medical patients; Outpatients; Prophylaxis; Venous thromboembolism

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; AWARENESS; CONTINUING EDUCATION; EDUCATION PROGRAM; EVALUATION; FEMALE; GERMANY; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; IMMOBILIZATION; MALE; MEDICAL STUDENT; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; RETROSPECTIVE STUDY; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PHYSICIANS; PREMEDICATION; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 33845450332     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029606296392     Document Type: Article

References (14)

1. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 ; 126 (3 Suppl). 338S - 338S.
2. Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospitalised medical patients. J Clin Pathol 1997 ; 50: 609-609.
3. Cohen AT, Edmondson RA, Phillips MJ, et al. The changing pattern of venous thromboembolic disease. Haemostasis 1996 ; 26: 65-65.
4. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: Are we detecting enough deep vein thrombosis? J R Soc Med 1989 ; 82: 203-203.
5. Nicolaides AN, Breddin HK, Fareed J, et al. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 2001 ; 20: 1-1.
6. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: Analysis of the MEDENOX Study. Arch Intern Med 2004 ; 164: 963-963.
7. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 1992 ; 152: 1660-1660.
8. Carter CJ, Samama MM. Characteristics associated with the risk of venous thrombosis. In: Verstraete M, Fuster V, Topol EJ, Verstraete M, eds. Cardiovascular Thrombosis: Thrombocardiology and Thromboneurology. 2nd ed. Philadelphia: Lippincott-Raven, 1998: 91-91.
9. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: The Sirius study. Arch Intern Med 2000 ; 160: 3415-3415.
10. Cogo A, Bernardi E, Prandoni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994 ; 154: 164-164.
11. Lutz L, Haas S, Hach-Wunderle V, et al. Venous thromboembolism in internal medicine: Risk assessment and pharmaceutical prophylaxis. Med Welt 2002 ; 53: 231-231.
12. Samama MM, Cohen AT, Darmon J-Y, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999 ; 341: 793-793.
13. Bosson J-L, Pouchain D, Dubourg V, et al. The incidence of clinical venous thromboembolism and use of ambulatory prophylaxis methods in bedridden acutely ill medical out-patients: The ETAPE Study [abstract]. Blood 2004 ; 104 ( 11 Suppl Pt 1):Abstract 1760.
14. Bergmann J-F, Mouly S. Thromboprophylaxis in medical patients: Focus on France. Semin Thromb Hemost 2002 ; 28 (Suppl 3). 51-51.